HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safe administration of subsequent mRNA COVID-19 vaccine doses following a possible allergic reaction to the first dose.

AuthorsM S Roth, S Chantraine, C A Morales Mateluna, K Hartmann, C T Berger
JournalJournal of the European Academy of Dermatology and Venereology : JEADV (J Eur Acad Dermatol Venereol) Vol. 36 Issue 11 Pg. e880-e883 (11 2022) ISSN: 1468-3083 [Electronic] England
PMID35771081 (Publication Type: Letter)
Chemical References
  • COVID-19 Vaccines
  • RNA, Messenger
Topics
  • COVID-19 (prevention & control)
  • COVID-19 Vaccines (adverse effects)
  • Humans
  • Hypersensitivity
  • RNA, Messenger

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: